高级搜索
恶性肿瘤并发蛋白尿病人治疗后尿的变化及临床意义[J]. 肿瘤防治研究, 2002, 29(04): 319-321. DOI: 10.3971/j.issn.1000-8578.3301
引用本文: 恶性肿瘤并发蛋白尿病人治疗后尿的变化及临床意义[J]. 肿瘤防治研究, 2002, 29(04): 319-321. DOI: 10.3971/j.issn.1000-8578.3301
The treatment of the cancer patients with proteinuria[J]. Cancer Research on Prevention and Treatment, 2002, 29(04): 319-321. DOI: 10.3971/j.issn.1000-8578.3301
Citation: The treatment of the cancer patients with proteinuria[J]. Cancer Research on Prevention and Treatment, 2002, 29(04): 319-321. DOI: 10.3971/j.issn.1000-8578.3301

恶性肿瘤并发蛋白尿病人治疗后尿的变化及临床意义

The treatment of the cancer patients with proteinuria

  • 摘要: 目的 探讨恶性肿瘤并发蛋白尿病人治疗后尿的变化及临床意义。方法 对 2 90例病人治疗后尿的变化及临床表现观察记录, 并设对照组统计比较。结果 治疗组 2 33例中蛋白尿消失 39例 (16 .9% ), 减少78例 (33.5 % ), 化疗、放疗、是否合并血尿等对蛋白尿的变化均无显著影响 (均P >0 .0 5 )。治疗后蛋白尿消失和减少与临床上肿瘤消长呈高度相关, 相关系数r均在 0 .96以上。蛋白尿减少和消失较无变化或加重者存活时间长 (χ2 =11.6 8,P <0 .0 1)。结论 蛋白尿的变化可做为肿瘤诊断、治疗方案选择、疗效判定、估计预后的临床指标之一。

     

    Abstract: Objective To study the treatment results of the cancer patients with protienuria . Methods 290 cancer patients with protienuria were divided into two groups:the treated group and the controlled group.All the patients clinical manifestation and the changes in urine after having been treated were monitored.The data of the patients were contrasted by analysis of controlled-trials. Results In treatment group,the proteinuria disappeared in 39 cases(16.9%),and proteinuria reduced in 78 cases (33.5%).The chemot...

     

/

返回文章
返回